- Home
- WDI vs MDXG Comparison
WDI vs MDXG Comparison
Compare WDI & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WDI | MDXG |
|---|---|---|
| Founded | 2021 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 715.3M | 625.6M |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | WDI | MDXG |
|---|---|---|
| Price | $12.39 | $4.57 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 232.0K | ★ 918.8K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | ★ 11.80% | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 1.12 | N/A |
| Revenue | N/A | ★ $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $13.02 |
| P/E Ratio | $11.17 | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $12.51 | $3.03 |
| 52 Week High | $15.28 | $7.97 |
Technical Indicators
Market Signals| Indicator | WDI | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 19.47 | 55.63 |
| Support Level | N/A | $4.11 |
| Resistance Level | $13.86 | $4.76 |
| Average True Range (ATR) | 0.10 | 0.19 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 3.03 | 53.85 |
Price Performance
Historical ComparisonAbout WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income. As a secondary investment objective, the Fund will seek capital appreciation. The fund seeks to achieve its investment objectives by investing, under normal market conditions, across fixed income sectors and securities in seeking to deliver a well-diversified portfolio.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.